AMT-130 Huntington’s gene therapy data, FDA Phase III sham-trial push, cash runway, and 2026 catalysts—read now.
The Evolution of Wheat Protein in the 2026 Market The trajectory of the plant protein market is increasingly defined by the “hydrolysate” movement. While isolated proteins were the standard for the ...
Why an overlooked data entry point is creating outsized cyber risk and compliance exposure for financial institutions.
This isn't just a badge for us; it’s a commitment to our clients that their digital transformation is backed by ...
WASHINGTON, DC, UNITED STATES, March 2, 2026 /EINPresswire.com/ -- Designing Enterprise AI Systems, Governance ...
Leading Milwaukee contractor announces expanded service offerings and faster project timelines to serve more homeowners ...
LONG BEACH, CA - February 20, 2026 - PRESSADVANTAGE - A newly released educational resource offers a detailed, ...
AWS’s Hilary Tam on why sustainability leaders must shift from compliance to commercial value creation - and how data, AI and cloud make it possible ...
February 23, 2026 - PRESSADVANTAGE - Infintech Designs has reached a milestone of 26 years in business, establishing ...
Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) and ...
Firm describes how combined design, maintenance, and tree services align with evolving safety, water, and property use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results